Array Biopharma Inc (NASDAQ:ARRY)

4.03
Data as of Nov 28
 +0.08 / +2.03%
Today’s Change
2.98
Today|||52-Week Range
6.07
-19.56%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$521.3M

Company Description

Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. Its proprietary drug development pipeline is primarily focused on the treatment of cancer and inflammatory disease and includes clinical candidates that are designed to regulate therapeutically important targets. The company also discovers and develops drug candidates across a broad range of therapeutic areas in collaboration with leading pharmaceutical and biotechnology companies such as AstraZeneca, Novartis, InterMune and Roche. Array BioPharma was founded by Kevin Koch, Anthony Piscopio, K.C. Nicolaou and David L. Snitman in 1998 and is headquartered in Boulder, CO.

Contact Information

Array BioPharma, Inc.
3200 Walnut Street
Boulder Colorado 80301
P:(303) 381-6600
Investor Relations:
(303) 386-1193

Employees

Shareholders

Other institutional58.88%
Mutual fund holders34.12%
Individual stakeholders15.07%

Top Executives

Ron SquarerChief Executive Officer & Director
David L. SnitmanChief Operating Officer & VP-Business Development
R. Michael CarruthersChief Financial Officer & Head-Investor Relations
Nick A. SaccomanoChief Scientific Officer
Robert E. WinklerVice President-Clinical Research & Development

To view my watchlist

Not a member yet?

Sign up now for a free account

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2014 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2014. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2014 and/or its affiliates.